See highlights from the Global Science Summit

FAST Announces Funding For First Innovative Seed Grant

FAST has awarded its first Innovative Seed Grant to Drs. Rachel Cunningham and Jennifer Adair to develop a safer, more accessible hematopoietic stem cell therapy approach for Angelman syndrome that avoids risky chemotherapy-based conditioning.

What are you looking for?

Find information on Angelman syndrome, research, clinical trials, resources, and ways to get involved.